We’re sitting down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and cutting-edge technology within the industry. With a career dedicated to pushing the boundaries of innovation, Ivan offers a unique perspective on how science and tech intersect
In a landmark effort to strengthen health security across Southeast Asia, Australia and Thailand have embarked on a transformative partnership that promises to reshape the region’s approach to public health, bringing new hope for resilience. Announced on August 11, this collaboration brings
In a landscape where over 50% of pharmaceuticals distributed in the US are manufactured overseas, the fragility of the drug supply chain has become a pressing concern for national health security, prompting urgent action. Imagine a scenario where a global crisis disrupts access to essential
In a landscape where economic volatility often shakes investor confidence, Becton Dickinson (BDX) has emerged as a standout performer, recently revising its full-year earnings outlook upward with an adjusted diluted EPS guidance of $14.30 to $14.45, reflecting a robust 9.4% growth at the midpoint.
The pharmaceutical industry stands on the brink of a technological revolution with the recent release of the Good Automated Manufacturing Practice (GAMP) Artificial Intelligence Guide by the International Society for Pharmaceutical Engineering (ISPE). As pharmaceutical companies increasingly turn
The cell and gene therapy (CGT) market is undergoing rapid expansion as it transforms healthcare with innovative treatments for previously incurable diseases. This exhilarating growth is projected to reach $28 billion by the year 2030, marking a significant milestone. Experts attribute this
